NCT01016951 - A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

HealthyCOPD

Interventions

DRUG

AZD9164 Turbuhaler®

"Dry powder for inhalation via Turbuhaler, MAD. Starting dose in healthy volunteers is 400 µg with up to two dose escalations not exceeding AstraZeneca pre-defined exposure limits.~The COPD patients will receive a dose of 1000 µg."

DRUG

Placebo Turbuhaler®

Dry powder for inhalation via Turbuhaler, MAD

Trial Locations (2)

Unknown

Research Site, Linköping

Research Site, Luleå